RTW Biotech Opportunities (RTW) Competitors GBX 1.32 +0.00 (+0.15%) As of 08/1/2025 11:16 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock RTW vs. ATT, MYI, N91, FEV, WWH, PNL, WTAN, VEIL, BRW, and PINShould you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include Allianz Technology Trust (ATT), Murray International (MYI), Ninety One Group (N91), Fidelity European Trust (FEV), Worldwide Healthcare (WWH), Personal Assets (PNL), Witan Investment Trust (WTAN), Vietnam Enterprise (VEIL), Brewin Dolphin (BRW), and Pantheon International (PIN). These companies are all part of the "asset management" industry. RTW Biotech Opportunities vs. Its Competitors Allianz Technology Trust Murray International Ninety One Group Fidelity European Trust Worldwide Healthcare Personal Assets Witan Investment Trust Vietnam Enterprise Brewin Dolphin Pantheon International RTW Biotech Opportunities (LON:RTW) and Allianz Technology Trust (LON:ATT) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment. Which has more volatility & risk, RTW or ATT? RTW Biotech Opportunities has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, Allianz Technology Trust has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500. Does the media prefer RTW or ATT? In the previous week, RTW Biotech Opportunities and RTW Biotech Opportunities both had 2 articles in the media. Allianz Technology Trust's average media sentiment score of 1.63 beat RTW Biotech Opportunities' score of 1.13 indicating that Allianz Technology Trust is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RTW Biotech Opportunities 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Allianz Technology Trust 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better valuation & earnings, RTW or ATT? RTW Biotech Opportunities has higher revenue and earnings than Allianz Technology Trust. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than Allianz Technology Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRTW Biotech Opportunities£2.12B0.21£14.09B£0.423.15Allianz Technology Trust£511.77M3.40£502.74M£132.423.45 Do insiders and institutionals believe in RTW or ATT? 3.9% of RTW Biotech Opportunities shares are owned by institutional investors. Comparatively, 31.7% of Allianz Technology Trust shares are owned by institutional investors. 16.2% of RTW Biotech Opportunities shares are owned by company insiders. Comparatively, 2.1% of Allianz Technology Trust shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is RTW or ATT more profitable? RTW Biotech Opportunities has a net margin of 664.38% compared to Allianz Technology Trust's net margin of 98.24%. Allianz Technology Trust's return on equity of 34.32% beat RTW Biotech Opportunities' return on equity.Company Net Margins Return on Equity Return on Assets RTW Biotech Opportunities664.38% 25.18% -0.47% Allianz Technology Trust 98.24%34.32%22.44% SummaryAllianz Technology Trust beats RTW Biotech Opportunities on 7 of the 12 factors compared between the two stocks. Get RTW Biotech Opportunities News Delivered to You Automatically Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RTW vs. The Competition Export to ExcelMetricRTW Biotech OpportunitiesAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£443.41M£1.29B£6.33B£3.03BDividend YieldN/A4.40%4.19%5.02%P/E Ratio3.1522.3614.03176.74Price / Sales0.212,556.001,858.76264,367.15Price / Cash0.3260.70127.5327.97Price / Book0.011.452.244.54Net Income£14.09B£265.04M£1.23B£5.90B7 Day Performance2.33%-0.34%-0.46%-0.92%1 Month Performance9.09%0.63%1.90%6.15%1 Year Performance-21.43%6.54%19.37%71.63% RTW Biotech Opportunities Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RTWRTW Biotech OpportunitiesN/AGBX 1.32+0.2%N/A-22.8%£443.41M£2.12B3.154,971Positive NewsATTAllianz Technology TrustN/AGBX 453+1.5%N/A+22.5%£1.72B£511.77M3.42N/APositive NewsMYIMurray InternationalN/AGBX 287.36+0.3%N/A+9.4%£1.71B£198.15M9.56N/ADividend AnnouncementN91Ninety One Group1.4703 of 5 starsGBX 193.10-1.1%GBX 190-1.6%+10.3%£1.71B£586.81M11.121,180FEVFidelity European TrustN/AGBX 408.36-0.4%N/A-0.9%£1.68B£221.98M8.09N/APositive NewsWWHWorldwide HealthcareN/AGBX 312+0.5%N/A-14.2%£1.66B£245.62M7.26N/ANews CoveragePositive NewsHigh Trading VolumePNLPersonal AssetsN/AGBX 514.22+0.0%N/A+4.1%£1.64B£107.31M13.11N/ANews CoveragePositive NewsWTANWitan Investment TrustN/AN/AN/AN/A£1.58B£246.38M738.896VEILVietnam EnterpriseN/AGBX 683.990.0%N/A+20.8%£1.57B£17.87M-461.98N/AHigh Trading VolumeBRWBrewin DolphinN/AN/AN/AN/A£1.56B£415.46M3,029.412,186PINPantheon InternationalN/AGBX 336+0.1%N/A-2.0%£1.55B£72.76M50.32455News CoverageEarnings Report Related Companies and Tools Related Companies ATT Alternatives MYI Alternatives N91 Alternatives FEV Alternatives WWH Alternatives PNL Alternatives WTAN Alternatives VEIL Alternatives BRW Alternatives PIN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:RTW) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
